Lexicon Pharmaceuticals Inc (LXRX)
2.40
+0.21
(+9.59%)
USD |
NASDAQ |
Mar 28, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Price to Book Value: 6.347 for March 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 28, 2024 | 6.347 |
March 27, 2024 | 5.792 |
March 26, 2024 | 5.236 |
March 25, 2024 | 5.606 |
March 22, 2024 | 5.977 |
March 21, 2024 | 6.373 |
March 20, 2024 | 6.585 |
March 19, 2024 | 6.453 |
March 18, 2024 | 6.664 |
March 15, 2024 | 6.876 |
March 14, 2024 | 6.426 |
March 13, 2024 | 6.559 |
March 12, 2024 | 6.664 |
March 11, 2024 | 7.431 |
March 08, 2024 | 5.739 |
March 07, 2024 | 5.686 |
March 06, 2024 | 5.761 |
March 05, 2024 | 5.919 |
March 04, 2024 | 5.813 |
March 01, 2024 | 6.524 |
February 29, 2024 | 6.550 |
February 28, 2024 | 6.866 |
February 27, 2024 | 6.892 |
February 26, 2024 | 6.418 |
February 23, 2024 | 6.681 |
Date | Value |
---|---|
February 22, 2024 | 6.234 |
February 21, 2024 | 6.602 |
February 20, 2024 | 6.971 |
February 16, 2024 | 8.365 |
February 15, 2024 | 9.417 |
February 14, 2024 | 8.733 |
February 13, 2024 | 7.707 |
February 12, 2024 | 7.681 |
February 09, 2024 | 6.287 |
February 08, 2024 | 6.050 |
February 07, 2024 | 5.656 |
February 06, 2024 | 5.813 |
February 05, 2024 | 5.392 |
February 02, 2024 | 5.603 |
February 01, 2024 | 5.208 |
January 31, 2024 | 4.919 |
January 30, 2024 | 4.630 |
January 29, 2024 | 5.050 |
January 26, 2024 | 4.788 |
January 25, 2024 | 4.682 |
January 24, 2024 | 4.551 |
January 23, 2024 | 4.209 |
January 22, 2024 | 3.630 |
January 19, 2024 | 3.420 |
January 18, 2024 | 3.420 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.393
Minimum
Sep 25 2023
9.417
Maximum
Feb 15 2024
4.021
Average
3.737
Median
Price to Book Value Benchmarks
Novavax Inc | -- |
OPKO Health Inc | 0.6021 |
Protalix BioTherapeutics Inc | 2.742 |
AIM ImmunoTech Inc | 1.050 |
Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 440.12 |
PEG Ratio | -0.0963 |
Price | 2.40 |
Earnings Yield | -33.33% |
Market Cap | 590.97M |
PEGY Ratio | -0.0963 |